Aim: Because of the delayed rise of serum creatinine concentrations, novel biomarkers such as NGAL, GST and KIM-1 are proposed to detect acute kidney injury (AKI). In this study we evaluated these biomarkers. Materials & methods: Twenty-six consecutive adult liver transplantations were evaluated. Markers were measured at four different time points during an intensive care unit admission. Results: Plasma NGAL detected AKI with an optimal area under the curve at 8 h after admission (0.86; p = 0.004) and at 4 h after admission for urinary NGAL (0.80; p = 0.012). The other markers failed to detect AKI. Conclusion: NGAL is a promising biomarker for detecting AKI in patients after liver transplantation.

cystatin C, glutathione S-transferase, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, serum creatinine
dx.doi.org/10.2217/bmm.13.91, hdl.handle.net/1765/65152
Biomarkers in Medicine
Department of Intensive Care

Dedeoğlu, B, de Geus, H.R.H, Fortrie, G, & Betjes, M.G.H. (2013). Novel biomarkers for the prediction of acute kidney injury in patients undergoing liver transplantation. Biomarkers in Medicine, 7(6), 947–957. doi:10.2217/bmm.13.91